John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cloudflare
NET
|
+$299M |
| 2 |
Advanced Micro Devices
AMD
|
+$249M |
| 3 |
Pfizer
PFE
|
+$227M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$212M |
| 5 |
NVIDIA
NVDA
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$241M |
| 2 |
Cisco
CSCO
|
+$234M |
| 3 |
Analog Devices
ADI
|
+$198M |
| 4 |
Mondelez International
MDLZ
|
+$185M |
| 5 |
Philip Morris
PM
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.01% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 10.3% |
| 4 | Industrials | 9.92% |
| 5 | Financials | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Utah Medical Products
UTMD
$223M
| $290K | ﹤0.01% |
+2,899
| New | +$296K |
|
|
SAIL
3652
PUT
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $290K | ﹤0.01% |
6,000
-11,000
| -65% | -$539K |
|
3653
HCW Biologics
HCWB
$4.9M
| $289K | ﹤0.01% |
+520
| New | +$353K |
|
3654
CALL
Qfin Holdings
QFIN
$1.14B
| $289K | ﹤0.01% |
12,600
-11,600
| -48% | -$258K |
|
3655
Team
TISI
$107M
| $289K | ﹤0.01% |
26,504
+17,327
| +189% | +$346K |
|
|
SEV
3656
DELISTED
Sono Group N.V. Common Shares
SEV
| $289K | ﹤0.01% |
+30,031
| New | +$452K |
|
3657
CALL
Scotiabank
BNS
$114B
| $287K | ﹤0.01% |
4,000
-4,000
| -50% | -$264K |
|
3658
CALL
Gen Digital
GEN
$17.8B
| $286K | ﹤0.01% |
+11,000
| New | +$278K |
|
3659
Holley
HLLY
$349M
| $286K | ﹤0.01% |
+22,053
| New | +$267K |
|
3660
InflaRx
IFRX
$357M
| $286K | ﹤0.01% |
60,169
+49,099
| +444% | +$197K |
|
|
CNCE
3661
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $286K | ﹤0.01% |
90,900
+54,476
| +150% | +$181K |
|
|
CTRA
3662
CALL
DELISTED
Coterra Energy
CTRA
| $285K | ﹤0.01% |
15,000
-59,900
| -80% | -$1.25M |
|
|
GAN
3663
PUT
DELISTED
GAN Ltd
GAN
| $285K | ﹤0.01% |
31,000
+9,900
| +47% | +$121K |
|
3664
CALL
Mattel
MAT
$4.33B
| $285K | ﹤0.01% |
13,200
-4,200
| -24% | -$88.1K |
|
3665
Q32 Bio
QTTB
$485M
| $285K | ﹤0.01% |
4,352
-4,600
| -51% | -$446K |
|
3666
CALL
Dave & Buster's
PLAY
$345M
| $284K | ﹤0.01% |
7,400
-1,600
| -18% | -$59.3K |
|
|
CTHR
3667
DELISTED
Charles & Colvard Ltd
CTHR
| $284K | ﹤0.01% |
9,823
+1,629
| +20% | +$48.8K |
|
3668
CALL
1-800-Flowers.com
FLWS
$242M
| $283K | ﹤0.01% |
12,100
-1,900
| -14% | -$55.2K |
|
3669
Gyre Therapeutics
GYRE
$701M
| $282K | ﹤0.01% |
41,140
+33,931
| +471% | +$580K |
|
3670
CALL
IQVIA
IQV
$43B
| $282K | ﹤0.01% |
1,000
| – | – |
|
3671
CALL
Dollar Tree
DLTR
$25.4B
| $281K | ﹤0.01% |
2,000
-15,000
| -88% | -$1.82M |
|
3672
CALL
United Natural Foods
UNFI
$2.88B
| $280K | ﹤0.01% |
5,700
-85,200
| -94% | -$4.12M |
|
3673
CALL
Unum
UNM
$14.4B
| $280K | ﹤0.01% |
+11,400
| New | +$292K |
|
|
CHX
3674
CALL
DELISTED
ChampionX
CHX
| $279K | ﹤0.01% |
+13,800
| New | +$325K |
|
3675
CALL
LivePerson
LPSN
$33.6M
| $279K | ﹤0.01% |
+520
| New | +$361K |
|
Similar funds
John Overdeck's Q4 2021 Portfolio in Review
As of Q4 2021, John Overdeck held 5,171 positions worth $46.8B, up 4.6% from $44.7B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
John Overdeck's Q4 2021 filing shows 995 new, 1,525 increased, 1,628 reduced and 977 closed positions. Its largest new stake was Cloudflare: 1,781,661 shares worth $234M. The largest sale was Lam Research, an estimated $241M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- John Overdeck's largest Q4 2021 buy was Cloudflare: 1,781,661 shares worth $234M.
- John Overdeck added most to Advanced Micro Devices in Q4 2021, an estimated $249M increase.
- John Overdeck's biggest Q4 2021 reduction was Mondelez International, cutting an estimated $185M.
- John Overdeck fully exited Lam Research in Q4 2021, selling an estimated $241M.
- John Overdeck's ten largest holdings make up 5.7% of its $46.8B portfolio in Q4 2021.
- John Overdeck opened 995 new positions and closed 977 in Q4 2021.
- John Overdeck's portfolio value rose 4.6% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q4 2021, filed 14 Feb 2022.